Aarey Drugs Fined ₹ 5,900 for Delayed Submission of Related Party Transactions

Aarey Drugs & Pharmaceuticals Ltd. has been fined ₹ 5,900 by the Bombay Stock Exchange (BSE) and National Stock Exchange of India Limited (NSE) for non-compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company failed to submit related party transactions in the specified format and within the prescribed timeline for the half year ended September 30, 2025. The fine is ₹ 5,000 plus GST (18%). The board has assured that necessary steps have been taken to strengthen internal compliance monitoring mechanisms to prevent recurrence of such instances.